RENAAL Study Investigators
Wilcoxon test Kruskal Wallis test, Mann Whitney test and Fisher exact test were done for the results
Injectable formulations from PlexusDx are compounded at licensed 503A pharmacies, ensuring pharmaceutical-grade quality without the premium cost of branded versions
The program comprises nine pivotal trials spanning obesity, type 2 diabetes, cardiovascular disease, knee osteoarthritis, sleep apnea, MASLD, low back pain, and renal outcomes
Always use a fresh, sterile needle for every injection.
Icosapent ethyl (brand name Vascepa) : While not a direct glucose-lowering medication, this purified fish oil derivative was approved in December 2019 for cardiovascular risk reduction in adults with T2D and established cardiovascular disease, addressing a significant comorbidity